AbCellera Biologics Inc

NASDAQ:ABCL  
31.72
-2.42 (-7.09%)
Earnings Announcements

Abcellera Reports Full Year 2020 Business Results

Published: 03/29/2021 20:20 GMT
AbCellera Biologics Inc (ABCL) - Abcellera Reports Full Year 2020 Business Results.
Revenue is expected to be $87.32 Million
Adjusted EPS is expected to be $0.12

Next Quarter Revenue Guidance is expected to be $55.67 Million
Next Quarter EPS Guidance is expected to be $0.05

More details on our Analysts Page.